Pennsylvania Psychiatric Institute Advancement in Recovery Program - Harrisburg Pennsylvania

Pennsylvania Psychiatric Institute Advancement in Recovery Program - Harrisburg, PA

Pennsylvania Psychiatric Institute Advancement In Recovery Program is treatment center located at 2501 North 3rd Street in the 17110 zip code in Harrisburg, PA that offers medication-assisted substance use treatment. It accepts people with co-occurring substance use and mental disorders, people with trauma and adult women into its treatment program. Pennsylvania Psychiatric Institute Advancement In Recovery Program provides naltrexone administration, suboxone prescription and relapse prevention from naltrexone to children and adolescents. Some of the treatment approaches used by Pennsylvania Psychiatric Institute Advancement In Recovery Program consist of relapse prevention, rational emotive behavioral therapy and motivational interviewing.

Address: 2501 North 3rd Street, Harrisburg, PA 17110

  1. Types of Care
  2. Service Settings
  3. Hospitals
  4. Opioid Medications used in Treatment
  5. Type of Alcohol Use Disorder Treatment
  6. Type Of Treatment
  7. Pharmacotherapies
  8. Treatment Approaches
  9. FacilityOwnership
  10. License/Certification/Accreditation
  11. Payment/Insurance/Funding Accepted
  12. Special Programs/ Population Groups Supported
  13. Assessment/Pre-treatment
  14. Screening & Testing
  15. Transitional Services
  16. Ancillary Services
  17. Other Addictions Treatment
  18. Counseling Services and Education
  19. Tobacco/Screening Services
  20. Facility Smoking Policy
  21. Age Groups Accepted
  22. Gender Accepted

Here are the full facility listing details on Pennsylvania Psychiatric Institute Advancement in Recovery Program in Harrisburg, PA:

Types of Care at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Substance use treatment
  • Treatment for co-occurring serious mental health illness/serious emotional disturbance and substance use disorders

Service Settings at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Outpatient treatment
  • Intensive outpatient treatment
  • Outpatient methadone/buprenorphine or naltrexone treatment
  • Regular outpatient treatment

Hospitals at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Psychiatric hospital

Opioid Medications used in Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Methadone used in Treatment
  • Buprenorphine used in Treatment
  • Naltrexone used in Treatment

Type of Alcohol Use Disorder Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • This facility administers/prescribes medication for alcohol use disorder

Type Of Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • buprenorphine maintenance
  • methadone maintenance
  • suboxone prescription
  • naltrexone administration
  • relapse prevention from naltrexone

Pharmacotherapies at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Methadone
  • Buprenorphine with naloxone (Ex. Suboxone)
  • Buprenorphine without naloxone
  • Buprenorphine (extended-release, injectable, for example, Sublocade)
  • Naltrexone (oral)
  • Naltrexone (extended-release, injectable naltrexone - Vivitrol)
  • Medications for psychiatric disorders

Treatment Approaches at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • brief intervention
  • cognitive behavioral therapy
  • contingency management/motivational incentives
  • motivational interviewing
  • matrix Model
  • rational emotive behavioral therapy
  • relapse prevention
  • substance use counseling
  • trauma-related counseling
  • 12-step facilitation

FacilityOwnership at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • a private non-profit organization

License/Certification/Accreditation at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • State substance abuse agency
  • State department of health
  • Hospital licensing authority
  • The Joint Commission

Payment/Insurance/Funding Accepted at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Federal, or any government funding for substance use programs
  • IHS/Tribal/Urban (ITU) funds
  • Medicare
  • Medicaid
  • Military insurance
  • Private health insurance
  • Cash or self-payment
  • State-financed health insurance plan other than Medicaid

Special Programs/ Population Groups Supported at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • adult women
  • pregnant/postpartum women
  • adult men
  • people with co-occurring substance use and mental disorders
  • people with trauma

Assessment/Pre-treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Comprehensive substance use assessment
  • Interim services for clients
  • Outreach to persons in the community

Screening & Testing at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Breathalyzer or blood alcohol testing
  • Drug or alcohol urine screening
  • HIV testing
  • Screening for Hepatitis B
  • Screening for Hepatitis C
  • Screening for mental disorders
  • Screening for substance use
  • STD testing
  • TB screening
  • Testing for metabolic syndrome

Transitional Services at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Aftercare/continuing care
  • Discharge Planning
  • Naloxone and overdose education

Ancillary Services at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • case management
  • housing services
  • mental health services
  • social skills development

Other Addictions Treatment at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Treatment for non-substance use addiction disorder

Counseling Services and Education at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • individual counseling
  • group counseling
  • family counseling
  • marital/couples counseling
  • substance use education
  • employment counseling or training
  • vocational training and educational support

Tobacco/Screening Services at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Nicotine replacement therapy
  • Non-nicotine smoking/tobacco cessation medications
  • Screening for tobacco use
  • Smoking/tobacco cessation counseling

Facility Smoking Policy at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • Smoking not permitted

Age Groups Accepted at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • children and adolescents

Gender Accepted at Pennsylvania Psychiatric Institute Advancement In Recovery Program

  • women
  • men

Phone #: 717-782-6844

Call (866) 434-2077 for 24/7 help with treatment.

SPONSORED AD

Is Methadone a safe option for addiction treatment?

Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at Pennsylvania Psychiatric Institute Advancement in Recovery Program. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.

Here are some key points to consider regarding the safety of methadone treatment:

  1. Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.

  2. Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.

  3. Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).

  4. Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.

  5. Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.

However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.

Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like Pennsylvania Psychiatric Institute Advancement in Recovery Program to conduct a thorough assessment before starting someone on methadone.

Other drug and rehab centers within 75 miles of Pennsylvania Psychiatric Institute Advancement in Recovery Program: